Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
Takubo
T
T
Department of Clinical and Laboratory Medicine, Osaka City University Medical School, Osaka, Japan. m3542254@med.osaka-cu.ac.jp
Kumura
T
T
Nishiki
S
S
Kinoshita
Y
Y
Koh
K
K
Ohta
K
K
Yamane
T
T
Hino
M
M
Kamitani
T
T
Tatsumi
N
N
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000150:complications; D053222:Fas Ligand Protein; D005260:Female; D017228:Hepatocyte Growth Factor / Q000097:blood*; D015616:Histiocytosis, Non-Langerhans-Cell / Q000097:blood* / Q000209:etiology / Q000601:surgery; D006801:Humans; D020382:Interleukin-18 / Q000097:blood*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D008562:Membrane Glycoproteins / Q000097:blood*; D009363:Neoplasm Proteins / Q000097:blood*; D011241:Prednisone / Q000008:administration & dosage; D011990:Receptors, Transferrin / Q000097:blood*; D013156:Splenectomy; D014412:Tumor Virus Infections / Q000150:complications; D014750:Vincristine / Q000008:administration & dosage; D019014:fas Receptor / Q000097:blood*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D020382:Interleukin-18; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D011990:Receptors, Transferrin; D019014:fas Receptor; D014750:Vincristine; D017228:Hepatocyte Growth Factor; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone